1. Acalabrutinib vs Rituximab Plus Idelalisib (IdR) or Bendamustine (BR) by Investigator Choice in Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia: Phase 3 ASCEND Study. (12th June 2019) Authors: Ghia, P.; Pluta, A.; Wach, M.; Lysak, D.; Kozak, T.; Simkovic, M.; Kaplan, P.; Kraychok, I.; Illes, A.; De La Serna, J.; Dolan, S.; Campbell, P.; Musuraca, G.; Jacob, A.; Avery, E.J.; Lee, J.H.; Chen, T.; Liang, W.; Patel, P.; Jurczak, W. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EXTRANODAL NATURAL KILLER (NK)/T‐CELL LYMPHOMA, NASAL TYPE – CASE REPORT AND REVIEW OF CZECH LYMPHOMA STUDY GROUP (CLSG) DATABASE. (12th June 2019) Authors: Steinerova, K.; Jindra, P.; Lysak, D.; Karas, M.; Trneny, M.; Klener, P.; Sykorova, A.; Belada, D.; Janikova, A.; Pytlik, R.; Prochazka, V.; Benesova, K.; Blahovcova, P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P668: ACALABRUTINIB VS RITUXIMAB PLUS IDELALISIB OR BENDAMUSTINE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: ASCEND RESULTS AT ~4 YEARS OF FOLLOW-UP. (23rd June 2022) Authors: Ghia, P.; Pluta, A.; Wach, M.; Lysak, D.; Simkovic, M.; Kriachok, I.; Illes, A.; de la Serna, J.; Dolan, S.; Campbell, P.; Musuraca, G.; Jacob, A.; Avery, E.; Lee, J. H.; Usenko, G.; Wang, M. H.; Yu, T.; Jurczak, W. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Portal vein embolization with stem cells application for enlargement of future liver remnant volume in primary non-resectable colorectal liver metastases. (April 2017) Authors: Treska, V.; Skalicky, T.; Fichtl, J.; Lysak, D.; Bruha, J.; Duras, P.; Mirka, H.; Finek, J. Journal: HPB Issue: Volume 19(2017)Supplement 1 Page Start: S7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Portal vein embolization with stem cells application for increasing future liver remnant volume in primary non-resectable colorectal liver metastases. (2019) Authors: Treska, V.; Fichtl, J.; Lysak, D.; Bruha, J.; Duras, P.; Liska, V.; Finek, J. Journal: HPB Issue: Volume 21(2019)Supplement 3 Page Start: S989 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗